Advancing Metabolic Infant Nutrition: The Latest in Early Years Formula Innovation

Join us for a 30-minute educational webinar with Rachel Powers, RD.
Learning Objectives:

• Explore the latest amino acid profile enhancements in Anamix® Early Years for MSUD, GA‑1, and MMA/PA and understand the clinical rationale driving these updates.
• Recognize the expanded indication for GA-1 Anamix Early Years to include pyridoxine‑dependent epilepsy (PDE) and learn best practices for using lysine‑free formulas in PDE management.
• Discover how the unique prebiotic oligosaccharide blend in Early Years supports gut health and the immune system.